OXYMETAZOLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxymetazoline patents expire, and what generic alternatives are available?
Oxymetazoline is a drug marketed by Sun Pharma Canada and is included in one NDA.
The generic ingredient in OXYMETAZOLINE is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYMETAZOLINE?
- What are the global sales for OXYMETAZOLINE?
- What is Average Wholesale Price for OXYMETAZOLINE?
Summary for OXYMETAZOLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for OXYMETAZOLINE |
| DailyMed Link: | OXYMETAZOLINE at DailyMed |
US Patents and Regulatory Information for OXYMETAZOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | OXYMETAZOLINE HYDROCHLORIDE | oxymetazoline hydrochloride | CREAM;TOPICAL | 213584-001 | Oct 4, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
